DE2150772A1 - METHOD FOR PREPARING 6-HYDROXY-2-PYRIDONE-3-CARBONIC ACID AMIDE COMPOUNDS - Google Patents
METHOD FOR PREPARING 6-HYDROXY-2-PYRIDONE-3-CARBONIC ACID AMIDE COMPOUNDSInfo
- Publication number
- DE2150772A1 DE2150772A1 DE19712150772 DE2150772A DE2150772A1 DE 2150772 A1 DE2150772 A1 DE 2150772A1 DE 19712150772 DE19712150772 DE 19712150772 DE 2150772 A DE2150772 A DE 2150772A DE 2150772 A1 DE2150772 A1 DE 2150772A1
- Authority
- DE
- Germany
- Prior art keywords
- alkyl
- hydrogen
- condensation
- general formula
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Description
CASSELLA FARBWERKE MAINKUR 2150772CASSELLA FARBWERKE MAINKUR 2150772
HEIm Ref HEIm Ref
Frankfurt(Main), den 8. 10. 1971 Dr.Eu/CzFrankfurt (Main), October 8, 1971 Dr.Eu/Cz
carbonsäureamid-Verbindungencarboxamide compounds
Die Erfindung betrifft ein neues Verfahren zur Herstellung von 6-Hydroxy-2-pyridon-3-carbonsäureamid-Verbindungen der allgemeinen FormelThe invention relates to a new method of manufacture of 6-hydroxy-2-pyridone-3-carboxamide compounds of the general formula
in der X Wasserstoff, eine Cyan-, eine Alkoxy-, eine gegebenenfalls verzweigte und/oder substituierte Alkyl-, gegebenenfalls verzweigte und/oder substituierte Alkenyl-, gegebenenfalls substituierte Cycloalkyl-, Aralkyl-, Arylgruppe oder einen heterocyclischen Rest,in which X is hydrogen, cyano, alkoxy, optionally branched and / or substituted alkyl, optionally branched and / or substituted alkenyl, optionally substituted cycloalkyl, aralkyl, aryl or a heterocyclic radical,
Y Wasserstoff, eine gegebenenfalls substituierte Amino-, gegebenenfalls verzweigte und/oder substituierte Alkyl-, gegebenenfalls verzweigte und/oder substituierte Alkenyl-, gegebenenfalls substituierte Cycloalkyl-, Aralkyl- oder Arylgruppe oder einen heterocyclischen Rest,Y is hydrogen, an optionally substituted amino, optionally branched and / or substituted alkyl, optionally branched one and / or substituted alkenyl, optionally substituted cycloalkyl, aralkyl or aryl group or a heterocyclic radical,
R. und/oder B„ Wasserstoff, eine Alkyl-, Hydroxyalkyl-, Alkoxyalkyl-, Cycloalkyl-, Aralkyl- oder Arylgruppe, wobei die Alkylreste R1 und R2 auchR. and / or B “hydrogen, an alkyl, hydroxyalkyl, alkoxyalkyl, cycloalkyl, aralkyl or aryl group, the alkyl radicals R 1 and R 2 also
3 0 9 8 16/1133 ORiGiNAL INSPECTED3 0 9 8 16/1133 ORiGiNAL INSPECTED
- 2 - Ref. 2927- 2 - Ref. 2927
direkt oder über ein Heteroatom verbunden sein können,can be linked directly or via a heteroatom,
bedeuten· Das erfindungsgemäße Verfahren ist dadurch gekennzeichnet, daß entweder eine Verbindung der allgemeinen Formel IIThe method according to the invention is characterized in that that either a compound of the general formula II
ZO-CO- CH2 - CO - X IIZO-CO- CH 2 - CO - X II
worin X die bereits oben angegebene Bedeutung besitzt und Z einen Alleylrest, vorzugsweise mit 1 bis 2 C-Atomen, bedeutet, mit einer Verbindung der allgemeinen Formel IIIwherein X has the meaning already given above and Z is an alleyl radical, preferably with 1 to 2 carbon atoms, means with a compound of the general formula III
HYN - CO - CH0 - CO -HYN - CO - CH 0 - CO -
kondensiert wird, oder daß eine Verbindung der allgemeinen Formel IVis condensed, or that a compound of the general formula IV
HYN - CO - CH2 - CO - X IVHYN - CO - CH 2 - CO - X IV
mit einer Verbindung der allgemeinen Formel Vwith a compound of the general formula V
ZO-CO- CH0 - CO -ZO-CO- CH 0 - CO -
kondensiert wird· In den Formeln III, IV und V besitzen X, Y, R1, R2 und Z die bereits genannte Bedeutung.condensation is carried out · In formulas III, IV and V, X, Y, R 1 , R 2 and Z have the meanings already mentioned.
Als Substituenten für Cycloalkyl- und für Arylgruppen in den Resten X, Y, R1 und R2 kommen beispielsweise ein oder mehrere Halogenatome, Cyan-, Alkyl- oder Alkoxygruppen in Betracht. In den Resten X und Y können die Alkyl- bzw.Suitable substituents for cycloalkyl and aryl groups in the radicals X, Y, R 1 and R 2 are, for example, one or more halogen atoms, cyano, alkyl or alkoxy groups. In the radicals X and Y, the alkyl or
309816/1133309816/1133
- 3 - Ref. 2927- 3 - Ref. 2927
Alkenylgruppen beispielsweise substituiert sein, durch eine Cyan—, Hydroxy—, Acyloxy—j Alkoxy—, Aryloxy— oder eine Alkyl- bzw. Arylamino-carbonyloxy-Gruppe. Ferner auch durch eine Mono- bzw« Dialkylaminogruppe, wobei die Alkylgruppen auch direkt oder über ein Heteroatom verbunden sein können. Bedeutet Y eine Aminogruppe, so kann diese durch Alkylgruppen mono- oder disubstituiert oder durch einen aliphatischen oder aromatischen Säurerest aoyliert sein.Alkenyl groups can be substituted, for example, by a cyano, hydroxy, acyloxy — j alkoxy, aryloxy or an alkyl or arylamino-carbonyloxy group. Further also by a mono- or dialkylamino group, the alkyl groups also directly or via a heteroatom can be connected. If Y is an amino group, this can be mono- or disubstituted by alkyl groups or be aoylated by an aliphatic or aromatic acid radical.
Die Kettenlänge der Alkyl- bzw. Alkenylgruppen in den Resten X und Y beträgt vorzugsweise 1-6 C-Atome« Ein heterocyclischer Rest für X und/oder Y kann beispielsweise eine Pyridyl-, Thiazolyl-, Benzthiazolyl-, Imidazolyl-, Benzimidazolyl-, Thienyl-, Furyl- oder eine Pyrrolylgruppe sein.The chain length of the alkyl or alkenyl groups in the X and Y radicals are preferably 1-6 carbon atoms. A heterocyclic radical for X and / or Y can, for example a pyridyl, thiazolyl, benzthiazolyl, imidazolyl, benzimidazolyl, thienyl, furyl or be a pyrrolyl group.
Als Cycloaikylgruppen kommen beispielsweise Cyclopropylbis Cyclooctylreste, vorzugsweise Cyclopentyl- oder Cyclohexylreste in Betracht.As cycloalkyl groups, for example, cyclopropyl bis cyclooctyl radicals, preferably cyclopentyl or Cyclohexyl radicals into consideration.
Das erfindungsgemäße Verfahren dient hauptsächlich zur Herstellung von Verbindungen, bei denen in der allgemeinen Formel I die Alkylgruppen in den Resten X, Y, R- und R2 1 - k Kohlenstoffatome, insbesondere 1 oder 2 Kohlenstoffatome, besitzen und vorzugsweise zur Herstellung von solchen Verbindungen der allgemeinen Formel I, bei denenThe process according to the invention is mainly used for the preparation of compounds in which in general formula I the alkyl groups in the radicals X, Y, R- and R 2 have 1- k carbon atoms, in particular 1 or 2 carbon atoms, and preferably for the preparation of such compounds of the general formula I, in which
309816/1 133309816/1 133
- k - Ref. 2927- k - Ref. 2927
bedeuten, wobei die Alkylreste 1 bis 4 Kohlenstoffatome, insbesondere 1 bis 2 Kohlenstoffatome, besitzen.mean, where the alkyl radicals 1 to 4 carbon atoms, especially 1 to 2 carbon atoms.
Für die 6-Hydroxy-2-pyridon-3-carbonsäureamide der allgemeinen Formel I sind tautomere Formen denkbar, beispielsweise:Tautomeric forms are conceivable for the 6-hydroxy-2-pyridone-3-carboxamides of the general formula I, for example:
HOHO
Y YY Y
Ib IcIb Ic
und falls Y Wasserstoff bedeutet auch noch z.B.and if Y is hydrogen also e.g.
IfIf
309816/ 1309816/1
- 5 - Ref. 2927- 5 - Ref. 2927
Im Rahmen der vorliegenden Anmeldung sollen in der Beschreibung und in den Ansprüchen auch die möglichen tautomeren Formen verstanden sein.In the context of the present application, the description and claims should also include the possible be understood tautomeric forms.
Die erfindungsgemäße Kondensation einer Verbindung der allgemeinen Formel II mit einer Verbindung der allgemeinen Formel III bzw. die Kondensation einer Verbindung der allgemeinen Formel IV mit einer Verbindung der allgemeinen Formel V verläuft unter Austritt des Alkohols ZOH nach folgendem Schema:The inventive condensation of a compound of the general formula II with a compound of the general formula III or the condensation of a compound of the general formula IV with a compound of the general formula V proceeds with the exit of the Alcohol ZOH according to the following scheme:
O=CO = C
H2C-C-N^H 2 CCN ^
ü-N\ü- N \
HYNHYN
IIII
O =0O = 0
IIIIII
• A• A
=0= 0
=c= c
I C=OI C = O
IVIV
Die Kondensation wird vorzugsweise in einem organischen Lösungs- bzw. Verdünnungsmittel in Gegenwart eines alkalischen Kondensationsmittels, zweckmäßigerweise bei Temperaturen von 0 - 1000C1 durchgeführt. Als Lösung·- bzw. Verdünnungsmittel wird vorzugsweise ein niederer Alkohol,The condensation is preferably carried out in an organic solvent or diluent in the presence of an alkaline condensing agent, expediently at temperatures from 0 - 100 0 C performed. 1 The preferred solution or diluent is a lower alcohol,
309816/1133309816/1133
- 6 -> Ref. 2927- 6 - > Ref. 2927
beispielsweise Äthanol, verwendet. Als alkalische Kondensationsmittel sind zum Beispiel Natrium- und Kaliumalkoholate, insbesondere Natrium- und Kalium— äthylat und Natrium- und Kaliumcarbonat zu nennen.for example, ethanol is used. As alkaline Examples of condensation agents are sodium and Potassium alcoholates, especially sodium and potassium to name ethylate and sodium and potassium carbonate.
Es ist bekannt (DOS 2 045 851), 6-Hydroxy-2-pyridon-3-carbonsäureamid-Verbindungen durch Verseifung der entsprechenden 3-Cyan-Verbindungen mittels 94 bis 97#igerIt is known (DOS 2 045 851), 6-hydroxy-2-pyridone-3-carboxamide compounds by saponification of the corresponding 3-cyano compounds using 94 to 97 # iger
Schwefelsäure bei 5O-6O°C herzustellen. Dieses Verfahren liefert aber in vielen Fällen keine reine 6-Hydroxy-2-pyridon-3-carbonsäureamid-Verbindungen, da durch vollständige Verseifung der Nitrtlgruppe zur Carbonsäure und Abspaltung von Kohlensäure die entsprechenden 6—Hydroxy-2—pyridon-Verbindungen mitgebildet werden. Die nach dem erfindungsgemäßen Verfahren dargestellten 6-Hydroxy-2-pyridon-3-carbonsäureamid-Verbindungen besitzen dagegen eine hohe Reinheit.To produce sulfuric acid at 50-60 ° C. This method but in many cases does not provide pure 6-hydroxy-2-pyridone-3-carboxamide compounds, since by complete saponification of the nitrate group to the carboxylic acid and splitting off of carbonic acid the corresponding 6 — hydroxy-2 — pyridone compounds are also formed. the have 6-hydroxy-2-pyridone-3-carboxamide compounds prepared by the process according to the invention on the other hand, a high degree of purity.
Es ist ferner bekannt (U.Basu, Journ.Ind.Chem.Soc.1935» Seite 306), 4-Methyl-6-hydroxy-2-pyridon-3-carbonsäureamid durch Kondensation von ß-Amino-crotonsäureäthylester mit Malonsäurediamid herzustellen. Das erfindungsgemäße Verfahren ist wirtschaftlicher als dieses bekannte Verfahren, da als Ausgangsmaterial zur Herstellung von 4-Methyl-6-hydroxy-2-pyridon-3-carbonsäureamid der Acetessigsäureäthylester als Ausgangsmaterial dient,It is also known (U.Basu, Journ.Ind.Chem.Soc.1935 » Page 306), 4-methyl-6-hydroxy-2-pyridone-3-carboxamide by condensation of ß-amino-crotonic acid ethyl ester with malonic acid diamide. The inventive Process is more economical than this known process because it is used as a starting material for the production of 4-methyl-6-hydroxy-2-pyridone-3-carboxamide of the ethyl acetoacetate is used as the starting material,
309816/ 1 133309816/1 133
- 7 - Ref. 2927- 7 - Ref. 2927
während der ß—Amino—erotonsäureäthylester erst ans: dem Acetessigsäureäthylester mittels Ammoniak hergestellt werden muß.while the ß-amino-erotonic acid ethyl ester only ans: dem Ethyl acetoacetate must be prepared by means of ammonia.
Die nach dem erfindungsgemäßen Verfahren hergestellten Verbindungen sind wertvolle Zwischenprodukte, die insbesondere zur Herstellung von Farbstoffen, vorzugsweise Azofarbstoffen, geeignet sind.The compounds prepared by the process according to the invention are valuable intermediates, in particular for the production of dyes, preferably azo dyes, are suitable.
Zu einer Lösung aus 6OO Gerichtsteilen Äthylalkohol, 255 Gewichtsteilen Malonsäurediamid und 390 Gewichtsteilen Acetessigsäureäthylester wird in 2 Stunden bei 40-45°C eine Lösung von 210 Gewichtsteilen Ätzkali in 1000 Gewichtsteilen Äthylalkohol einlaufen gelassen. Anschließend wird die Reaktionslösung in 4 Stunden auf 85°C erhitzt und 6 Stunden bei dieser Temperatur gehalten. Dann wird der Äthylalkohol abdestilliert, der Rückstand in 2000 Gewichtsteilen Wasser gelöst und das gebildete ^-Methyl-6-hydroxy-2-pyridon-3-earbonsäureamid durch Versetzen mit 460 Gewichtsteilen Salzsäure 30$ig ausgefällt. Es wird abgesaugt, mit Wasser gewaschen und getrocknet.To a solution of 600 meal parts of ethyl alcohol, 255 parts by weight of malonic acid diamide and 390 parts by weight Ethyl acetoacetate becomes a in 2 hours at 40-45 ° C Solution of 210 parts by weight of caustic potash in 1000 parts by weight of ethyl alcohol run in. Then will the reaction solution is heated to 85 ° C. in 4 hours and kept at this temperature for 6 hours. Then the Ethyl alcohol is distilled off, the residue dissolved in 2000 parts by weight of water and the formed ^ -Methyl-6-hydroxy-2-pyridon-3-carboxamide by adding 460 parts by weight Hydrochloric acid precipitated in 30%. It is filtered off with suction, washed with water and dried.
Analyse: C-HgO5N2 berechnet: 16,7% N.Analysis: C-HgO 5 N 2 calculated: 16.7% N.
gefunden: 16,5% N.found: 16.5% N.
-Die gleiche Verbindung wird erhalten, wenn in dem Beispiel das Malonsäurediamid und der Acetessigsäureäthylester ersetzt werden durch äquimolekulare Mengen von Malonsäuremonoamid-monoäthylester und Acetessigsäureamide-The same connection is obtained when in the example the malonic acid diamide and the ethyl acetoacetate are replaced by equimolecular amounts of monoethyl malonate and acetoacetic acid amides
309816/ 1133309816/1133
Ref. 2927Ref. 2927
In der folgenden Tabelle sind weitere nach dem erfindungsgemäßen Verfahren hergestellte 6-IIydroxy-2-pyridon—3-carbonsäureamide angeführt:In the following table are further according to the invention 6-II-hydroxy-2-pyridone-3-carboxamides made by the process listed:
,R., R.
HOHO
(Io Rs(Io R s
• ί
Y • ί
Y
No. XNo. X
bzw. tautomere Formen·or tautomeric forms
Brutto- Berechnet Gefunden formel # N # NGross Calculated Found formula # N # N
1. -C1. -C
2H5 2 H 5
2. -C3H7(U)2. -C 3 H 7 (U)
-H -II -H C8H10O3N2 -II -H -H C9H12O3N2 -H -II-HC 8 H 10 O 3 N 2 -II -H-HC 9 H 12 O 3 N 2
3. -C3H7(ISo) -H -H -H3. -C 3 H 7 (ISo) -H -H -H
4. -C4H9 (n) -H -H -Π4. -C 4 H 9 (n) -H -H -Π
5. -C4H9(iso) -H -Π -H5. -C 4 H 9 (iso) -H -Π -H
6. -C4H9(SeIi) -H -H -II6. -C 4 H 9 (SeIi) -H -H -II
7. -C2H0(tert) -H -H -H7. -C 2 H 0 (tert) -H-H -H
10. -CII-CH0 "II -TI -II10. -CII-CH 0 "II -TI -II
-CIl"-CIl "
11. -C * -II -II -II11. -C * -II -II -II
CH2 CH 2
12. -CH-CH-CH,. -H -H -H12. -CH-CH-CH ,. -H -H -H
14,3
14,3
13,3
13,3
13,3
13,314.3
14.3
13.3
13.3
13.3
13.3
8. -C5H11CiSo) -H -H -H C11H16O3N2 12,58. -C 5 H 11 CiSo) -H -H-HC 11 H 16 O 3 N 2 12.5
9. -C6H13(n) -II -H -Π C12II18O3N2 11,89. -C 6 H 13 (n) -II -H -Π C 12 II 18 O 3 N 2 11.8
15,615.6
14,414.4
15,6 14,6 14,1 13,7 13,2 13,6 13,015.6 14.6 14.1 13.7 13.2 13.6 13.0
12,9 11,6 1.1S, 2 14,012.9 11.6 1. 1 S, 2 14.0
14,214.2
309M6/ 1133309M6 / 1133
No, XNo, X
R2 Bruttoformel R 2 gross formula
Ref. 2927Ref. 2927
Berechnet GefundenCalculated Found
% N # N % N # N
-H -H -H C6HgO N2 18,2-H -H-HC 6 HgO N 2 18.2
—Η -H —Η CRHinO. Np 14,1-Η -H -Η C R H in O. Np 14.1
-H -H -H C12H16O3N2 11,9-H -H-HC 12 H 16 O 3 N 2 11.9
-H -H -H C13H12O3N2 11,5-H -H-HC 13 H 12 O 3 N 2 11.5
-H -H -H C12H10O3N2 12,2-H -H-HC 12 H 10 O 3 N 2 12.2
18,618.6
14,5 11,714.5 11.7
11,8 11,811.8 11.8
-H -H -H C10H8O4N2 12,7 12,4-H -H-HC 10 H 8 O 4 N 2 12.7 12.4
C CHC CH
20. -CH2-CH2-CN20. -CH 2 -CH 2 -CN
21. -CH2-CH2-OH21. -CH 2 -CH 2 -OH
22. -CH2-CH2-OCH3 -H -H -H C11H9O3N3 18,222. -CH 2 -CH 2 -OCH 3 -H-H -HC 11 H 9 O 3 N 3 18.2
-H -H -H C9H9O3N3 20,3-H -H-HC 9 H 9 O 3 N 3 20.3
-H -H -H C8H10O4N2 14,1-H -H-HC 8 H 10 O 4 N 2 14.1
-H -H -H C9H12O4N2 13,3-H -H-HC 9 H 12 O 4 N 2 13.3
9H12O4N2 9 H 12 O 4 N 2
23.-CH2-CH2-O-CO-CH3 -H -H -23.-CH 2 -CH 2 -O-CO-CH 3 -H -H -
24.-CHgCH2-O-CO-NH-C2H5 -H -H -H C11H15O5N3 15,624.-CHgCH 2 -O-CO-NH-C 2 H 5 -H-H -HC 11 H 15 O 5 N 3 15.6
25, 7H\ CH25, 7H \ CH
-H -H -H 11,1-H -H -H 11.1
CH3 26. /~\__CH, -H -H -H C14H14O3N2 10,9CH 3 26. / ~ \ __ CH, -H -H-HC 14 H 14 O 3 N 2 10.9
18,618.6
20,720.7
13,613.6
11,3 15,211.3 15.2
11,6 10,511.6 10.5
309816/1133309816/1133
- 10 - Ref. 2927- 10 - Ref. 2927
ν η ρ Brutto- Berechnet Gefunden x ttl tt2 formel # N % Nν η ρ gross calculated Found x tt l tt 2 formula # N % N
27. -27.-
28. -28.-
-H -H -H C13H20O3N2 11,1-H -H-HC 13 H 20 O 3 N 2 11.1
-H -H -H-H -H -H
29. -C8H17(SeIc) -H29. -C 8 H 17 (SeIc) -H
30. -C8H17(iso) -H30. -C 8 H 17 (iso) -H
31. -C17H35(n) -H31. -C 17 H 35 (n) -H
32. -CH3 -CH3 32. -CH 3 -CH 3
33. -C2H5 -CH3 33. -C 2 H 5 -CH 3
34. -C3H7(n) -CH3 34. -C 3 H 7 (n) -CH 3
35. -C3H7(ISo) -CH3 35. -C 3 H 7 (ISo) -CH 3
36. -C4H9(n) -CH3 36. -C 4 H 9 (n) -CH 3
37. -C4H9(ISo) -CH3 37. -C 4 H 9 (ISo) -CH 3
38. -C4H9(SeIc) -CH3 38. -C 4 H 9 (SeIc) -CH 3
39. -C.Ho(tert) -CH,39. -CH o (tert) -CH,
40. -40. -
-CH-CH
41. -C6H13 (n) -CH3 41. -C 6 H 13 (n) -CH 3
42. -C7H15 (n) -CH3 42. -C 7 H 15 (n) -CH 3
43. -C7H15(ISo) -CH3 43. -C 7 H 15 (ISo) -CH 3
44. -C8H17(SeIc) -CH3 44. -C 8 H 17 (SeIc) -CH 3
45. -C8H17(ISo) -CH3 45. -C 8 H 17 (ISo) -CH 3
46. -C17H35(n) -CH3 46. -C 17 H 35 (n) -CH 3
-H-H
-H -H -H -H -H -H-H -H -H -H -H -H
-H -H -H -H -H -H -H -H -H -H -H-H -H -H -H -H -H -H -H -H -H -H
-H-H
-H-H
-H-H
-H 11,1-H 11.1
-H C14H22°3N2 10'5 - HC 14 H 22 ° 3 N 2 10 ' 5
-H » 10,5-H »10.5
-H C23H40O3N2 7,1-HC 23 H 40 O 3 N 2 7.1
-H C8H10O3N2 15,4-HC 8 H 10 O 3 N 2 15.4
-H C9H12O3N2 14,3-HC 9 H 12 O 3 N 2 14.3
-H C10II14O3N2 13,3-HC 10 II 14 O 3 N 2 13.3
-H · 13,3-H · 13.3
12,5
12/5
12,5
12,512.5
12/5
12.5
12.5
-H C12H18O3N2 11,8-HC 12 H 18 O 3 N 2 11.8
-H C13H20O3N2 11,1
-H C14H22O3N2 10,5
-H " 10,5-HC 13 H 20 O 3 N 2 11.1
-HC 14 H 22 O 3 N 2 10.5
-H "10.5
H C15H24O3N2 10,0
H n 10,oHC 15 H 24 O 3 N 2 10.0
H n 10, o
H C24H42O3N2 6,9HC 24 H 42 O 3 N 2 6.9
11,6 11,4 10,1 10,3 6,9 15,7 14,8 13,0 13,611.6 11.4 10.1 10.3 6.9 15.7 14.8 13.0 13.6
12,3 12,212.3 12.2
12,712.7
12,112.1
12,0 11,6 10,0 10,712.0 11.6 10.0 10.7
10,5 10,710.5 10.7
309816/1133309816/1133
R. R„ Bruttoformel R. R "Gross formula
Ref. 2927Ref. 2927
Berechnet GefundenCalculated Found
$ N # N $ N # N
47. -CH=CH2 47. -CH = CH 2
48. -48.-
^ cn=cnf ^ cn = cn f
49. -CH=CH-Cl49. -CH = CH-Cl
50. -CH=Cl2 50. -CH = Cl 2
-H-H
56. -CH2-CH2-OH -H -H C9H10O3N2 14,456. -CH 2 -CH 2 -OH -H-HC 9 H 10 O 3 N 2 14.4
-CH3 -H -H C10H12O3N2 13,5-CH 3 -H-HC 10 H 12 O 3 N 2 13.5
-CH3 -H -H C9II9O3N2Cl 12,3-CH 3 -H-HC 9 II 9 O 3 N 2 Cl 12.3
-CH3 -H -H C9H8O3N2Cl2 10,7-CH 3 -H -HC 9 H 8 O 3 N 2 Cl 2 10.7
51. -Cn=CH-CH3 -CH3 -H -H C10H12O3N2 13,551. -Cn = CH-CH 3 -CH 3 -H -HC 10 H 12 O 3 N 2 13.5
-CH3 -H -H C7H8O3N2 16,7-CH 3 -H-HC 7 H 8 O 3 N 2 16.7
-CH3 -H -H C13H18O3N2 11,2-CH 3 -H-HC 13 H 18 O 3 N 2 11.2
-CH3 -H -H C14H14O3N2 10,9-CH 3 -H-HC 14 H 14 O 3 N 2 10.9
55. -CH2-CH2-CN -CH3 -H -H C10H11O3N3 19,055. -CH 2 -CH 2 -CN -CH 3 -H -HC 10 H 11 O 3 N 3 19.0
-CH3 -H -H C9H12O4N2 13,3-CH 3 -H-HC 9 H 12 O 4 N 2 13.3
57. -CH2-CH2-OCH3 -CH3 -H -H C10H14O4N2 12,457. -CH 2 -CH 2 -OCH 3 -CH 3 -H -HC 10 H 14 O 4 N 2 12.4
58.-CH2-CH2-O-CO-CH3 -CH3 -H -H58.-CH 2 -CH 2 -O-CO-CH 3 -CH 3 -H -H
59. -/πΛ—OCH3 59. - / πΛ-OCH 3
60. J/ V-Cl60. J / V-Cl
01. jT\ 01. jT \
Ga. -CH2- f y Ga. -CH 2 - fy
-CH3 -H -H-CH 3 -H -H
11,011.0
10,010.0
-H -H C13H31O3N2Cl 10,1-H-HC 13 H 31 O 3 N 2 Cl 10.1
-CH, -H -H C1-H19O-Np 11,5-CH, -H-HC 1 -H 19 O-Np 11.5
13H12O3N2 13 H 12 O 3 N 2
CH3 -Π -HCH 3 -Π -H
14,2 13,814.2 13.8
12,7 11,2 13,8 17,1 11,512.7 11.2 13.8 17.1 11.5
11,511.5
19,4 13,0 12,0 11,5 10,719.4 13.0 12.0 11.5 10.7
10,5 11,810.5 11.8
10,3 . 10,510.3. 10.5
0 9; 16/11330 9; 16/1133
-T-T
H1, H 1 H 1 , H 1 BruttoformelGross formula
Ref. 2927Ref. 2927
Bor· Gef.Boron · Gef.
# N JC N# N JC N
63. Hf-JH -C CH63. Hf-JH -C CH
-CH.,-CH., -H -H-H -H
11,2 11,611.2 11.6
65. -CH,65. -CH,
-CH,-CH,
-C2H5 -H -H C14H11O3N3S 14,0 13,5 -C 2 H 5 -H-HC 14 H 11 O 3 N 3 S 14.0 13.5
-H -H C9H12O3N2 14,3 14,7 -H -H C,„H,q0-Np 11,8 11,2-H-HC 9 H 12 O 3 N 2 14.3 14.7 -H-HC, "H, q 0 -N p 11.8 11.2
-CH2-CH2-CN-CH 2 -CH 2 -CN
-CH2-CH2-OH-CH 2 -CH 2 -OH
-CHg-CHg-OCH--CHg-CHg-OCH- -H-HC-H-HC
19,0 19,519.0 19.5
-H -H C9H12O4N2 13,3 13,9 -H -H C10H14O4N2 12,4 13,0-H-HC 9 H 12 O 4 N 2 13.3 13.9 -H-HC 10 H 14 O 4 N 2 12.4 13.0
CH, 70. -CH3 -CHgCHgCH2-N^ ·> -H-H C12H19O3N3 16,6 16,2CH, 70. -CH 3 -CHgCHgCH 2 -N ^ •> -HH C 12 H 19 O 3 N 3 16.6 16.2
71. -CH_ -CH2-CH2-IiH-^H3 -H -H71. -CH_ -CH 2 -CH 2 -IiH- ^ H 3 -H -H
72. -CH3 72. -CH 3
73. -CH,73. -CH,
-NH-CH.-NH-CH. -H -H CJLxOJS1 -H -H CJL x OJS 1
7H9( 7 H 9 (
18,7 18,518.7 18.5
22,9 22,522.9 22.5
-H -H CgH11O3K3 21,4 21,0-H -H CgH 11 O 3 K 3 21.4 21.0
74. -CH,74. -CH,
75. -CH3 75. -CH 3
-NH-CO-CH,-NH-CO-CH, -H -H C9H11O4N3 18,7 18,5-H-HC 9 H 11 O 4 N 3 18.7 18.5 -H -H C11H16O3N2 12,5 12,0-H-HC 11 H 16 O 3 N 2 12.5 12.0
76. -CH,76. -CH,
77. -CH,77. -CH,
-CHsCH.-CHsCH.
-H -H C9H10O3N2 14,4 14,0-H-HC 9 H 10 O 3 N 2 14.4 14.0 -H -H C13H18O3N2 11,2 11,6-H-HC 13 H 18 O 3 N 2 11.2 11.6
309816/1133309816/1133
Ref. 2927Ref. 2927
No.No.
formelformula
78. -CH3 78. -CH 3
79. -CH3 80» -CH,79. -CH 3 80 »-CH,
-oh/-Oh/
-H -H -H-H -H -H
-H C14H14O3N2 10,9 10,5 -H C13H12O3N2 11,5 11,0 -H C11H10O4N2 12,0 12,5-HC 14 H 14 O 3 N 2 10.9 10.5 -HC 13 H 12 O 3 N 2 11.5 11.0 -HC 11 H 10 O 4 N 2 12.0 12.5
81.-CH2-CH2-CH2-NH2 _H _H _H 82.-CH2-CH2-CH2-CN -H -H -H81.-CH 2 -CH 2 -CH 2 -NH 2 _ H _ H _ H 82.-CH 2 -CH 2 -CH 2 -CN -H -H -H
I9, 9 20,3 19,0 19,4I 9, 9 20.3 19.0 19.4
83 .-CH2CH2CH2-OCH3 83.-CH 2 CH 2 CH 2 -OCH 3
. -CH2-NH-CH3 . -CH 2 -NH-CH 3
-H -H-H -H
-H C10H14O4N2 12,4 12,8-HC 10 H 14 O 4 N 2 12.4 12.8
-H -H -H C8H11O3N3 21,3 21,6-H -H-HC 8 H 11 O 3 N 3 21.3 21.6
-H -H-H -H
20,9 21,320.9 21.3
-CH3 -CH 3
-CH- -CH--CH- -CH-
-H -H -CH3 C8H10O3N2 15,4 15,0-H -H -CH 3 C 8 H 10 O 3 N 2 15.4 15.0
-H -CH3 -CH3 C9H13O3N2 14,3 14,0-H -CH 3 -CH 3 C 9 H 13 O 3 N 2 14.3 14.0
-CH3 -CH3 -CH3 C10H14O3N2 13,3 13,6-CH 3 -CH 3 -CH 3 C 10 H 14 O 3 N 2 13.3 13.6
-CH3 -C4H9(Ii) -H -C4H9(H) C15H24O3N2 10,0 10,5-CH 3 -C 4 H 9 (Ii) -H -C 4 H 9 (H) C 15 H 24 O 3 N 2 10.0 10.5
-CH3 -H -CH2CH2-OH -CHgCHgOH-CH 3 -H -CH 2 CH 2 -OH -CHgCHgOH
10,9 10,410.9 10.4
-CH3 -H -H -CH^CH2CHgOCH3 C11H16O4N2 11,7 11,5 -CH3 -CHgCH2OCH3 _H -CHgCHgOCH3 C13H20O5N2 10,1 10,5-CH 3 -H -H -CH 2 CH ^ CHgOCH 3 C 11 H 16 O 4 N 2 11.7 11.5 3 -CHgCH -CH 2 OCH 3 H _ -CHgCHgOCH 3 C 13 H 20 O 5 N 2 10 , 1 10.5
-CH3 -H-CH 3 -H
-H-H
C13H18°3N2 C 13 H 18 ° 3 N 2
3098 16/11333098 16/1133
Ref. 2927Ref. 2927
No. XNo. X
BruttoformelGross formula
Ber. Gef.Ber. Found
% N % N % N % N
. -CH3 -CH3 -H. -CH 3 -CH 3 -H
95. -CH3 -H -H95. -CH 3 -H -H
f~\ ci3Hi2°3N2 f ~ \ c i3 H i2 ° 3 N 2
O3N2 10,3 10,6 1>5 13L'8 O 3 N 2 10.3 10.6 1> 5 13L ' 8
96. -CH3 -H -CH2-CH2-O-CH2-CH2-11,8 12,296. -CH 3 -H -CH 2 -CH 2 -O-CH 2 -CH 2 -11.8 12.2
97. -CH3 -CH3 -CH2-CH2-97. -CH 3 -CH 3 -CH 2 -CH 2 - C10H12°3N2 13'5 C 10 H 12 ° 3 N 2 13 ' 5
98. -CH3 -C2H5 98. -CH 3 -C 2 H 5
-H -C-H -C
2H5 C11H16°3N2 12»5 2 H 5 C 11 H 16 ° 3 N 2 12 » 5
99. -CH3 -H99. -CH 3 -H
-H -C2H5 C9H12O3N2 14,3-H -C 2 H 5 C 9 H 12 O 3 N 2 14.3
100.100.
-H-H
-H-H
-C2H5 13,3 13,5-C 2 H 5 13.3 13.5
101. -C2H5 -CH3 101. -C 2 H 5 -CH 3
H -CHgCH2-OHH -CHgCH 2 -OH
11,7 12,111.7 12.1
H -C2H5 C14H22O3N2 10,5 10,3H -C 2 H 5 C 14 H 22 O 3 N 2 10.5 10.3
103. -CH3 103. -CH 3
-H 11,5 20,0-H 11.5 20.0
104. -CH,104. -CH,
C19H28°3N2 C 19 H 28 ° 3 N 2
309816/1133309816/1133
Claims (1)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19712150772 DE2150772A1 (en) | 1971-10-12 | 1971-10-12 | METHOD FOR PREPARING 6-HYDROXY-2-PYRIDONE-3-CARBONIC ACID AMIDE COMPOUNDS |
JP10121572A JPS4844263A (en) | 1971-10-12 | 1972-10-11 | |
GB4687772A GB1373314A (en) | 1971-10-12 | 1972-10-11 | Process for the preparation of 6-hydroxy-2-pyridone-3-carbonic acid amides |
FR7235922A FR2156231B1 (en) | 1971-10-12 | 1972-10-11 | |
CH1490172A CH568289A5 (en) | 1971-10-12 | 1972-10-12 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19712150772 DE2150772A1 (en) | 1971-10-12 | 1971-10-12 | METHOD FOR PREPARING 6-HYDROXY-2-PYRIDONE-3-CARBONIC ACID AMIDE COMPOUNDS |
Publications (1)
Publication Number | Publication Date |
---|---|
DE2150772A1 true DE2150772A1 (en) | 1973-04-19 |
Family
ID=5822115
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19712150772 Pending DE2150772A1 (en) | 1971-10-12 | 1971-10-12 | METHOD FOR PREPARING 6-HYDROXY-2-PYRIDONE-3-CARBONIC ACID AMIDE COMPOUNDS |
Country Status (5)
Country | Link |
---|---|
JP (1) | JPS4844263A (en) |
CH (1) | CH568289A5 (en) |
DE (1) | DE2150772A1 (en) |
FR (1) | FR2156231B1 (en) |
GB (1) | GB1373314A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0628547A1 (en) * | 1993-06-14 | 1994-12-14 | BASF Aktiengesellschaft | Process for the preparation of N-aminopyridones |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6049199A (en) | 1998-09-16 | 2000-04-03 | Dow Agrosciences Llc | 2-methoxyimino-2-(pyridinyloxymethyl)phenyl acetamides with (derivatised) hydroxyalkyl derivatives on the pyridine ring |
ES2546386T3 (en) * | 1999-07-20 | 2015-09-23 | Dow Agrosciences, Llc | Fungicide heterocyclic aromatic amides and their compositions, methods of use and preparation |
EP1516874B1 (en) * | 1999-07-20 | 2015-08-19 | Dow AgroSciences LLC | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
US7732616B2 (en) | 2003-11-19 | 2010-06-08 | Array Biopharma Inc. | Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof |
DE602004031037D1 (en) * | 2003-11-19 | 2011-02-24 | Array Biopharma Inc | HETEROCYCLIC INHIBITORS OF MEK |
US7517994B2 (en) | 2003-11-19 | 2009-04-14 | Array Biopharma Inc. | Heterocyclic inhibitors of MEK and methods of use thereof |
MY149960A (en) | 2005-05-18 | 2013-11-15 | Array Biopharma Inc | 4-(phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamide derivatives as mek inhibitors for the treatment of hyperproliferative diseases |
JP5020542B2 (en) | 2006-05-19 | 2012-09-05 | キヤノン株式会社 | Novel coloring compound and ink containing the coloring compound |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1263268A (en) * | 1968-12-11 | 1972-02-09 | Ici Ltd | 0-aminoalkyl-pyridin-2-ones |
-
1971
- 1971-10-12 DE DE19712150772 patent/DE2150772A1/en active Pending
-
1972
- 1972-10-11 GB GB4687772A patent/GB1373314A/en not_active Expired
- 1972-10-11 JP JP10121572A patent/JPS4844263A/ja active Pending
- 1972-10-11 FR FR7235922A patent/FR2156231B1/fr not_active Expired
- 1972-10-12 CH CH1490172A patent/CH568289A5/xx not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0628547A1 (en) * | 1993-06-14 | 1994-12-14 | BASF Aktiengesellschaft | Process for the preparation of N-aminopyridones |
US5466812A (en) * | 1993-06-14 | 1995-11-14 | Basf Aktiengesellschaft | Preparation of N-aminopyridones |
Also Published As
Publication number | Publication date |
---|---|
FR2156231B1 (en) | 1977-12-23 |
GB1373314A (en) | 1974-11-06 |
CH568289A5 (en) | 1975-10-31 |
FR2156231A1 (en) | 1973-05-25 |
JPS4844263A (en) | 1973-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2062001C2 (en) | 1,2,3,4-Tetrahydro-4-phenylisoquinoline derivatives, their acid addition salts, process for their production and pharmaceutical preparation | |
DE2150772A1 (en) | METHOD FOR PREPARING 6-HYDROXY-2-PYRIDONE-3-CARBONIC ACID AMIDE COMPOUNDS | |
DE1116221B (en) | Process for the production of ª ‰ ú¼ª ‰ -pentamethylene butyrolactone or salts of 3,3-pentamethylene-4-hydroxybutyric acid | |
DE1695633A1 (en) | Process for the preparation of new phenoxazine derivatives | |
DE1954706A1 (en) | Beta-adrenergic active imidazole derivs | |
DE1770538C3 (en) | Process for the preparation of 6,7-benzomorphane derivatives | |
DE890189C (en) | Process for the production of barbituric acid coagulations | |
DE1000822C2 (en) | Process for the preparation of pyridazone compounds | |
DE925168C (en) | Process for the preparation of derivatives of barbituric acid or thiobarbituric acid | |
DE2736230A1 (en) | 1,2-DIHYDROPYRAZINE DERIVATIVES | |
DE1077222B (en) | Process for the preparation of benzimidazolylidene compounds | |
DE2436032A1 (en) | NEW AROMATIC O-HYDROXYALDEHYDE, METHOD FOR THEIR PRODUCTION AND USE | |
AT208867B (en) | Process for the preparation of new substituted heterocyclic acid hydrazides | |
DE942327C (en) | Process for the preparation of benzimidazole-2-aldehydes or their diacetals | |
DE922048C (en) | Process for the preparation of pyrimidine derivatives | |
AT215996B (en) | Process for the preparation of new pyridine derivatives | |
DE1149004B (en) | Process for the preparation of 4-amino-1, 2, 5, 6-tetrahydrophosphorine- (arsenine) -3-carbonitriles substituted in the 1-position | |
DE738400C (en) | Process for the production of polyketones, ketocarboxylic and polycarboxylic acids | |
DE912094C (en) | Process for the preparation of pyrimidine derivatives | |
DE2318566A1 (en) | 3-ALKOXY-5-SUBSTITUTED PHENYL ACID ACIDS | |
AT215414B (en) | Process for the preparation of new β-hydroxybutyric acid amide derivatives | |
DE678152C (en) | Process for the preparation of 4,5-diketopyrrolidines | |
AT158647B (en) | Process for the preparation of 2-alkyl- or 2-phenylalkyl-4-amino-5-aminoalkylpyrimidines. | |
DE1158075B (en) | Process for the preparation of 4, 5, 5-trisubstituted oxazolidone- (2) -carboxamides- (4) | |
DE2262343A1 (en) | METHOD FOR MANUFACTURING KETONES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OHJ | Non-payment of the annual fee |